title: Alemtuzumab induction therapy in HIV-positive renal transplant recipients.
authors.affiliation: aDepartment of Renal Medicine, St George's Hospital bDepartment of Renal Sciences, King's College London cImperial College Kidney and Transplant Centre, Hammersmith Hospital dDepartment of HIV Medicine, Chelsea and Westminster Hospital eDivision of Infection and Immunity, University College London fDepartment of HIV Research, King's College Hospital NHS Foundation Trust, London, UK.
authors.forename: Florence E
authors.initials: FE
authors.lastname: Mclean
authors.forename: Esther
authors.initials: E
authors.lastname: Gathogo
authors.forename: Dawn
authors.initials: D
authors.lastname: Goodall
authors.forename: Rachael
authors.initials: R
authors.lastname: Jones
authors.forename: Sabine
authors.initials: S
authors.lastname: Kinloch
authors.forename: Frank A
authors.initials: FA
authors.lastname: Post
mesh_terms: D000074323:Alemtuzumab / Q000008:administration & dosage*; D006086:Graft vs Host Disease / Q000517:prevention & control*; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D051437:Renal Insufficiency / Q000601:surgery*; D066027:Transplant Recipients; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D000074323:Alemtuzumab